HomeVelpatasvir And Sofosbuvir

Velpatasvir And Sofosbuvir

Also known as: Sofosbuvir And Velpatasvir

Hepatitis C Virus Nucleotide Analog NS5B Polymerase InhibitorHepatitis C Virus NS5A InhibitorRNA Replicase Inhibitors

Route: Oral

Check Velpatasvir And Sofosbuvir Interactions →
23 interactions on record⛔ Black Box Warning

Velpatasvir And Sofosbuvir has 23 known drug interactions based on U.S. FDA drug labeling data. 5 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Carbamazepine, Rifampin, Rosuvastatin. Patients taking Velpatasvir And Sofosbuvir should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
23
Major
5
Moderate
7

Major (5)

Moderate (7)

Velpatasvir And Sofosbuvir + Tenofovir🟡Moderate

Regimens containing tenofovir DF ↑ tenofovir Monitor for tenofovir-associated adverse reactions in patients receiving EPCLUSA concomitantly with a regimen containing tenofovir DF. Refer to the prescribing information of the tenofovir DF-containing product for recommendations on renal monitoring. 7.4 Drugs without Clinically Significant Interactions with EPCLUSA Based on drug interaction studies conducted with the components of EPCLUSA (sofosbuvir or velpatasvir) or EPCLUSA, no clinically significant drug interactions have been observed or are expected with the following drugs [see Clinical Pharmacology (12.3) ]: EPCLUSA: atazanavir/ritonavir, buprenorphine/naloxone, cyclosporine, darunavir/ritonavir, dolutegravir, elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide, emtricitabine, methadone, naltrexone, raltegravir, or rilpivirine.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.